Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Aug 4, 2016 · 10-Q · 35 days after period end · 0001564590-16-022738
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Net Income | -$238.00K | -$6.01M | -$7.02M | -$8.42M |
| EPS Diluted | -$11.21 | $0.26 | -$0.47 | -$0.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 4, 2016 · 35 d after period end
